Literature DB >> 15562931

Prospective validation of a quantitative method for differentiating ischemic versus nonischemic cardiomyopathy by technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

Siu-Sun Yao1, Ehtasham Qureshi, Kenneth Nichols, George A Diamond, E Gordon Depuey, Alan Rozanski.   

Abstract

BACKGROUND: Myocardial perfusion single-photon emission computed tomography (SPECT) permits assessment of stress perfusion and resting left ventricular (LV) function. Quantitative analysis of perfusion patterns among patients with LV dysfunction offers an opportunity for developing criteria to differentiate ischemic from nonischemic cardiomyopathy. HYPOTHESIS: Quantitative assessment of SPECT may allow differentiation between ischemic and nonischemic cardiomyopathy.
METHODS: We evaluated 144 patients with LV ejection fraction < or =40%, divided into 63 patients with nonischemic and 81 with ischemic cardiomyopathy. Mean relative myocardial counts were obtained for regions drawn over defect and normal zones on rest and stress polar perfusion maps.
RESULTS: Multivariate logistic regression analysis of significant univariate SPECT predictors of ischemic cardiomyopathy revealed that the stress defect severity ratio (SDSR) was the best predictor of ischemic cardiomyopathy (p < 0.0001). By receiver operator characteristic (ROC) curve analysis, an SDSR of < or =45% optimized prediction of ischemic cardiomyopathy (sensitivity 81%, specificity 96%). An SDSR of < or =45% occurred in 65 of 81 (80%) patients with ischemic cardiomyopathy, but in only 3 of the 63 (4%) patients with nonischemic cardiomyopathy (p < 0.0001). Applying the < or =45% SDSR threshold to a prospective group of 89 patients yielded a somewhat lower sensitivity (60%), but retained high specificity (91%) for identifying ischemic cardiomyopathy (p = NS vs. retrospective group).
CONCLUSIONS: Presence of a severe and extensive stress perfusion defect is a hallmark of ischemic cardiomyopathy. By contrast, a mild stress perfusion defect (SDSR of >45%) is commonly present among patients with ischemic and nonischemic cardiomyopathy. An SDSR of < or =45% is a reproducible specific marker for identifying the presence of ischemic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562931      PMCID: PMC6654348          DOI: 10.1002/clc.4960271108

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

Review 1.  The role of radionuclide imaging in heart failure.

Authors:  Vinay Gulati; Gilbert Ching; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

2.  It's not all in the numbers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2015-03-24       Impact factor: 5.952

Review 3.  PET and SPECT in heart failure.

Authors:  Christoph Rischpler; Stephan Nekolla; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

4.  Role of Myocardial Perfusion Study in Differentiating Ischemic versus Nonischemic Cardiomyopathy Using Quantitative Parameters.

Authors:  Preeti Singh; Bhairavi Bhatt; Shwetal U Pawar; Ashish Kamra; Suruchi Shetye; Mangala Ghorpade
Journal:  Indian J Nucl Med       Date:  2018 Jan-Mar

Review 5.  Taxonomy of segmental myocardial systolic dysfunction.

Authors:  Adam K McDiarmid; Pierpaolo Pellicori; John G Cleland; Sven Plein
Journal:  Eur Heart J       Date:  2017-04-01       Impact factor: 29.983

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.